2022 Q1 Form 10-Q Financial Statement

#000121390022025966 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $36.58K $38.35K
YoY Change -4.62%
Cost Of Revenue $72.81K $39.36K
YoY Change 84.98%
Gross Profit -$36.23K -$1.010K
YoY Change 3487.13%
Gross Profit Margin -99.04% -2.63%
Selling, General & Admin $1.818M $1.313M
YoY Change 38.45% 26.85%
% of Gross Profit
Research & Development $1.205M $1.081M
YoY Change 11.46% 216.12%
% of Gross Profit
Depreciation & Amortization $28.53K $19.29K
YoY Change 47.9% 74.25%
% of Gross Profit
Operating Expenses $3.024M $2.395M
YoY Change 26.26% 73.86%
Operating Profit -$3.060M -$2.396M
YoY Change 27.72%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $1.740K $1.780K
YoY Change -2.25%
Pretax Income -$3.058M -$2.394M
YoY Change 27.74% 77.9%
Income Tax
% Of Pretax Income
Net Earnings -$3.058M -$2.394M
YoY Change 27.74% 77.9%
Net Earnings / Revenue -8359.94% -6242.28%
Basic Earnings Per Share -$0.19
Diluted Earnings Per Share -$188.9K -$213.0K
COMMON SHARES
Basic Shares Outstanding 16.19M shares
Diluted Shares Outstanding 16.19M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.87M $11.27M
YoY Change 14.15% 1408.78%
Cash & Equivalents $12.87M
Short-Term Investments
Other Short-Term Assets $315.1K $81.03K
YoY Change 288.87% -0.34%
Inventory $221.9K
Prepaid Expenses
Receivables $36.58K
Other Receivables $0.00
Total Short-Term Assets $13.44M $11.36M
YoY Change 18.38% 1270.49%
LONG-TERM ASSETS
Property, Plant & Equipment $523.0K $416.5K
YoY Change 25.57% 5.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $646.0K $561.9K
YoY Change 14.98% 0.21%
TOTAL ASSETS
Total Short-Term Assets $13.44M $11.36M
Total Long-Term Assets $646.0K $561.9K
Total Assets $14.09M $11.92M
YoY Change 18.22% 757.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $446.0K $345.8K
YoY Change 28.99% -67.9%
Accrued Expenses $362.0K $373.5K
YoY Change -3.1% 27.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $810.2K $750.4K
YoY Change 7.98% -88.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $156.0K $306.7K
YoY Change -49.12% 7.9%
Total Long-Term Liabilities $156.0K $306.7K
YoY Change -49.12% 7.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $810.2K $750.4K
Total Long-Term Liabilities $156.0K $306.7K
Total Liabilities $966.3K $1.057M
YoY Change -8.59% -83.92%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.12M $10.86M
YoY Change
Total Liabilities & Shareholders Equity $14.09M $11.92M
YoY Change 18.22% 757.82%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$3.058M -$2.394M
YoY Change 27.74% 77.9%
Depreciation, Depletion And Amortization $28.53K $19.29K
YoY Change 47.9% 74.25%
Cash From Operating Activities -$3.222M -$2.380M
YoY Change 35.37% 90.35%
INVESTING ACTIVITIES
Capital Expenditures -$93.32K -$2.060K
YoY Change 4430.1% -93.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$93.32K -$2.060K
YoY Change 4430.1% -93.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -320.0 6.527M
YoY Change -100.0% -38789.98%
NET CHANGE
Cash From Operating Activities -3.222M -2.380M
Cash From Investing Activities -93.32K -2.060K
Cash From Financing Activities -320.0 6.527M
Net Change In Cash -3.315M 4.145M
YoY Change -179.98% -419.58%
FREE CASH FLOW
Cash From Operating Activities -$3.222M -$2.380M
Capital Expenditures -$93.32K -$2.060K
Free Cash Flow -$3.128M -$2.378M
YoY Change 31.56% 94.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001500198
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
USD
CY2021Q1 nmtc Net Valuation Change Of Instruments Measured At Fair Value
NetValuationChangeOfInstrumentsMeasuredAtFairValue
USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q4 nmtc Issuance Of Common Stock Upon Vesting Of Restricted Stock Units
IssuanceOfCommonStockUponVestingOfRestrictedStockUnits
USD
nmtc Issuance Costs Attributed To Financing Activities
IssuanceCostsAttributedToFinancingActivities
USD
nmtc Revaluation Of Convertible Notes
RevaluationOfConvertibleNotes
USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
USD
nmtc Issuance Costs In Connection With Convertible Promissory Notes
IssuanceCostsInConnectionWithConvertiblePromissoryNotes
USD
nmtc Proceeds From Issuance Of Warrant In Connection With Private Placement
ProceedsFromIssuanceOfWarrantInConnectionWithPrivatePlacement
USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
nmtc Conversion Of Convertible Promissory Notes To Equity
ConversionOfConvertiblePromissoryNotesToEquity
USD
nmtc Unpaid Issuance Costs Attributed To Convertible Notes And Private Placement
UnpaidIssuanceCostsAttributedToConvertibleNotesAndPrivatePlacement
USD
nmtc Reclass Of Deferred Offering Costs To Additional Paidin Capital In Connection With Public Offering
ReclassOfDeferredOfferingCostsToAdditionalPaidinCapitalInConnectionWithPublicOffering
USD
nmtc Purchased Fixed Assets In Accounts Payable And Accrued Expenses
PurchasedFixedAssetsInAccountsPayableAndAccruedExpenses
USD
CY2021Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
USD
nmtc Operating Leases
OperatingLeases
USD
nmtc Operating Leases
OperatingLeases
USD
CY2022Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
USD
CY2022Q1 nmtc Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Periods
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriods
shares
CY2022Q1 nmtc Exercise Price Per Warrant Issued1
ExercisePricePerWarrantIssued1
CY2022Q1 nmtc Weighted Average Exercise Price Issued
WeightedAverageExercisePriceIssued
nmtc Weighted Average Termyears Issuedin Shares
WeightedAverageTermyearsIssuedinShares
CY2022Q1 nmtc Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Periods
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriods
shares
CY2022Q1 nmtc Weighted Average Exercise Price Exercised1
WeightedAverageExercisePriceExercised1
CY2022Q1 nmtc Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Pricee1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePricee1
nmtc Weighted Average Termyears Exercisedin Shares
WeightedAverageTermyearsExercisedinShares
nmtc Weighted Average Termyears Forfeitedin Shares
WeightedAverageTermyearsForfeitedinShares

Files In Submission

Name View Source Status
0001213900-22-025966-index-headers.html Edgar Link pending
0001213900-22-025966-index.html Edgar Link pending
0001213900-22-025966.txt Edgar Link pending
0001213900-22-025966-xbrl.zip Edgar Link pending
f10q0322ex31-1_neuroone.htm Edgar Link pending
f10q0322ex31-2_neuroone.htm Edgar Link pending
f10q0322ex32-1_neuroone.htm Edgar Link pending
f10q0322ex32-2_neuroone.htm Edgar Link pending
f10q0322_neuroonemedical.htm Edgar Link pending
f10q0322_neuroonemedical_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nmtc-20220331.xsd Edgar Link pending
nmtc-20220331_cal.xml Edgar Link unprocessable
nmtc-20220331_def.xml Edgar Link unprocessable
nmtc-20220331_lab.xml Edgar Link unprocessable
nmtc-20220331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending